Bortezomib

FDA Approved: * November 6, 2017
Pharm Company: * FRESENIUS KABI USA
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Bortezomib Overview

Bortezomib (BAN, INN and USAN; marketed as Velcade by Takeda Oncology; Chemobort by Cytogen and Bortecad by Cadila Healthcare) is an anti-cancer drug and the first therapeutic proteasome inhibitor to be used in humans. Proteasomes are cellular complexes that break down proteins. In some cancers, the proteins that normally kill cancer cells are broken down too quickly. Bortezomib interrupts this process and lets those proteins kill the cancer cells. It is approved in the U.S. and Europe for t...

Read more Bortezomib Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Bortezomib

Recent Bortezomib Forums: RSS Feed

gabantin-Bortezomib induced peripheral neuropathy(BINP)

I am a multiple myeloma patient, undergone 3 cycles of chemotherapy with bortezomib,and undergone autologus bonemarrow transplantaion.Suffering from BINP for last 5 months, commencing from second cycle of chemo.I am on dosage of 900mg for last 4 months,distributed equally thrice a day. I do not find much help. A patient who used a dosage of 1800 mg per day reported improvement. Little scared of the high dosage. Can I get some advice ? ## I am on gabapetin of 900 mg, distributed equally thrice a day. It was inadvertently omitted in my question.

Updated

Possible Dosages for this and Related Drugs:

Bortezomib
  • Injection: 2.5mg, 2.5mg/ml, 3.5mg, 3.5mg/1.4ml, 3.5mg/vial
  • Powder: 1mg/vial, 2.5mg/vial, 3.5mg/vial
  • Vial: 3.5mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Bortezomib: (1 result)

Sorted by National Drug Code
  • 63323-721 Bortezomib 1 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Fresenius Kabi USA, LLC

Other drugs which contain Bortezomib or a similar ingredient: (1 result)

Related Bortezomib Topics:

gabantin-Bortezomib induced peripheral neuropathy(BINP)
I am a multiple myeloma patient, undergone 3 cycles of chemotherapy with bortezomib,and undergone autologus bonemarrow t... 1 reply




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 20 October 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA